Adriamycin/cyclophosphamide combination chemotherapy: The importance of drug scheduling
- 30 November 1979
- journal article
- research article
- Published by Elsevier
- Vol. 15 (12) , 1503-1509
- https://doi.org/10.1016/0014-2964(79)90031-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Lack of vincristine-cyclophosphamide potentiation in different experimental tumour linesPublished by Elsevier ,1979
- Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapyPublished by Elsevier ,1978
- Experimental studies on the combination of radiation and chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Importance of schedule in adriamycin/cyclophosphamide combination chemotherapyPublished by Elsevier ,1978
- Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapyPublished by Elsevier ,1977
- ADRIAMYCIN-CYCLOPHOSPHAMIDE AND ADRIAMYCIN-CIS-DICHLORODIAMMINEPLATINUM(II) COMBINATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER1977
- ADRIAMYCIN AND CYCLOPHOSPHAMIDE IN ADVANCED BLADDER CANCER1977
- ADRIAMYCIN AND CYCLOPHOSPHAMIDE IN COMBINATION CHEMOTHERAPY OF L1210 LEUKEMIA1977
- Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemiaBritish Journal of Cancer, 1975